Navigation Links
Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
Date:5/14/2008

civir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.
Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Contact

Alan Roemer, Vice President

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: (609) 613-4125

Forward-Looking Statements

Pharmasset "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding our business that are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation the risk that adverse events could cause the cessation or delay of any of the ongoing or planned clinical trials (including, without limitation, the two additional cohorts of our ongoing Phase 1 clinical trial of R7128) and/or our development of our product candidates, the risk that R7128 shows no activity in HCV genotype 2 or 3 patients, the risk that we cannot enroll enough patients for the Phase 3 registration clinical trial for clevudine, the risk that our collaboration with Roche will not continue or will not be successful and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of these risks and uncertainties, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section of our Annual Report on Form 10-K for the fiscal year ended September 30, 2007 filed with the Securities and Exchange Commission entitled "Risk Factors" and discussions of potential risks and uncertainties in our subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
2. Pharmasset Commences Dosing in Phase 3 Registration Studies of Clevudine for HBV
3. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
4. Pharmasset Announces Clevudine and R7128 Presentations at HEP-DART
5. Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
6. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
7. Pharmasset Reports First Fiscal Quarter 2008 Financial Results
8. Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
9. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
10. Sinovac Commences Vaccination on Volunteers for Phase II Clinical Trial on Pandemic Influenza H5N1 Vaccine
11. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2008)... Proteolix, Inc., a,leader in the...hat target,protein degradation pathways in cancer...ta from two ongoing Phase 2 clinical trials of car... the upcoming 50th Annual Meeting of the,American...first in a new class,of specific proteasome inhib...
(Date:11/25/2008)...re-FirstCall/ -- Pharmacyclics, Inc.,(Nasdaq: P...ed a Phase 1,clinical trial with PCI-27483, the c...tor VIIa inhibitor. The trial was conducted in six...ty and pharmacologic effect of,PCI-27483. A singl... dose,response in the International Normalized Ra...
(Date:11/25/2008)...Call/ -- CardioVascular,BioTherapeutics, Inc. (OT...as,dosed the first patient in North America (NA) ...reat patients with severe coronary heart disease. ...nary heart Disease) trial will include,four rando...pproximately 120,patients with severe coronary he...
(Date:11/24/2008)...e/ -- Domino,s Pizza (NYSE: DPZ ), the,recogniz...o raise dough for,the kids of St. Jude Children,s... and Giving campaign. Domino,s customers will have...urchase to benefit the children of St. Jude.,Dona...when ordering online at, www.dominos.com . The ca...
Breaking Medicine Technology:Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 2Proteolix to Present Clinical and Preclinical Data at the 50th Annual Meeting of the American Society of Hematology 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 2Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 3Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483 4CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 2CVBT Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 3Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Domino's Pizza Pledges Support to the Fifth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3MyHealthGate Inc Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 27425 1MyHealthGate Inc Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 27425 2Ohios Regulation of RU 486 Clear and Constitutional Should Be Upheld Argues AUL in Brief Filed Before Ohio Supreme Court 27423 1Ohios Regulation of RU 486 Clear and Constitutional Should Be Upheld Argues AUL in Brief Filed Before Ohio Supreme Court 27423 2CPF Fundraisers Bring in Landmark Half Million Dollars in Less Than Three Weeks 27421 1CPF Fundraisers Bring in Landmark Half Million Dollars in Less Than Three Weeks 27421 2CPF Fundraisers Bring in Landmark Half Million Dollars in Less Than Three Weeks 27421 3A Mindful Chocolate Meditation 27418 1A Mindful Chocolate Meditation 27418 2
...care System and,Worker Productivity, SAN DIEGO, Ju...iosciences, Inc. announced today that results from... primary and transient,insomnia were presented thi...ies (APSS) Annual Meeting. APSS highlights show th...uts a significant,strain on the Healthcare System ...
...BUSINESS WIRE)--Jun,13, 2007 - Amgen (NASDAQ:AMGN)...YSE:WYE), today announced the presentation of,addi... Enbrel(R),(etanercept) was maintained with long-t...le rheumatoid arthritis (JRA) who,completed up to ...e,disease of childhood that is sometimes difficult...
Other Medicine Technology:Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 2Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 3Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 4Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 5Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 2Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 3Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 4Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 5Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 6Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 7Enbrel Safety Data for up to Eight Years in Patients with Juvenile,Rheumatoid Arthritis Being Presented at EULAR 8
(Date:12/1/2008)...re/ -- In the face of one of the most,severe econ... Health Board of,Directors has approved an invest...d the Sutter Health Retirement Plan. Employee pens...ocks and bonds, have been among the biggest,casua...conservatively,invested, the Sutter Health Retire...
(Date:12/1/2008)...l/ - The Westaim Corporation today announced it ha...of NUCRYST Pharmaceuticals Corp. to consider a ret...ately US$15 million or US$0.80 per share. Westaim ...he value of its 74.5 per cent stake in NUCRYST. Un...,s Board of Directors has 20 days to call a meetin...
(Date:12/1/2008).../ -- ETHICON, Inc., a Johnson & Johnson compa...stiture of its Professional Wound Care business to...saction are not being disclosed. , , Under ...has acquired the Professional Wound Care product p...brands as PROMOGRAN Matrix Wound Dressing, TIELLE ...
(Date:12/1/2008)...swire/ -- Democratic National Committee Chairman H...mmemorating World AIDS Day on its 20th Anniversary...n/prnh/20080519/DNCLOGO ) , , "It,s been 20...e have made strides, much work remains to be done ...lobal strategy. We must focus not only on prevent...
Breaking Medicine News(10 mins):Health News:Sutter Health Invests Hundreds of Millions in Employee Pension 2Health News:The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 2Health News:ETHICON Completes Divestiture of Professional Wound Care Business to One Equity Partners 3
...alif., "In light of the recent news event where a ...is (XDR-TB) flew on multiple airline flights and ...r rapid identification of MTB and assessment of dr... the disease" said Dr. Nani Dattagupta, Chief Scie...
...N.Y., Over one hundred Long Island AARP members ga...slation before the end of the 2007 Legislative Ses...rugs more affordable and help assure that their ce...took their message directly to their legislators d...
...ta is interested in having a third child, but the ...s autistic condition public . Travolta has not com...s autistic. However, a magazine editor, who inter... the view that if Travolta doesnt shy away from ac...
...the Group of Eight industrialized nations plan to ...fighting the HIV/AIDS pandemic during their upcomi...t week, German Chancellor Angela Merkel's spokespe...n Wednesday, Reuters reports. Wilhelm said details...
Other Medicine News:Health News:Long Island Seniors Rally for Rx Affordable Prescription Drugs and Cell Phone Protections 2Health News:Travolta Maybe Reluctant to Publicaly Discuss About Sons Autism 2Health News:G8 Members To Announce Plans To Increase HIV/AIDS Spending at Summit 2
...e HI VISION 8500 diagnostic ultrasound scanner com... operation for exceptional imaging and functionali...anced techniques for image enhancement and control...nding, wideband pulse-inversion, tissue harmonics,...
... a 2.4mm channel within a 12.1mm insertion tube. ...ultrasound image for improved reliability, an elec... and a 7.5 and 5.0mhz transducer for deeper ultras...or anatomical orientation and vascular evaluation ...
...CTRA 1400C are designed to achieve low daily opera...This system includes automated primary tube sampli...says in a single setup. It also has an integrated ...nce curves and patient sample dilutions to ensure ...
The ACL 7000 coagulation analyzer is the right choice for any laboratory that needs a full range of testing capabilities in a cost-effective system. You'll have access to a broad test menu including
Medicine Products: